AMV564, A CLINICALLY ACTIVE T CELL ENGAGER, INDUCES A TARGET-DEPENDENT ADAPTIVE IMMUNE RESPONSE

Eckard, S; Sarde, A; Mei, L; Ruegg, C; Chun, P; Smith, V

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (): A416